{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:53:33Z","timestamp":1740142413021,"version":"3.37.3"},"reference-count":50,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT Background Insulin resistance (IR), assessed by different criteria, is an important factor in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). More recently with the characterization of this metabolic dysfunction-associated fatty liver disease (MAFLD), one of the proposed criteria for this diagnosis has been the determination of the homeostasis model assessment-insulin resistance (HOMA-IR). Objective: The purpose of this study was to evaluate the relationship of HOMA-IR&gt;2.5 with clinical, metabolic, biochemical and histological data obtained in non-diabetic patients diagnosed with NAFLD by liver biopsy. Methods: Cross-sectional, retrospective study was carried out with data from 174 adult individuals of both genders with non-diabetics NAFLD, without obvious signs of portal hypertension. The body mass index (BMI) was classified according to the World Health Organization (1998), and the metabolic syndrome by the criteria of NCEP-ATP-III. Biochemical tests were evaluated using an automated method and insulinemia through immunofluorometric assay. Histological findings were classified according to Kleiner et al. (2005). Results: The mean age of the studied population was 53.6\u00b111.2 years, with 60.3% being female. The average BMI was 30.3 kg\/m2 and 75.9% of the patients had increased waist circumference. Among evaluated metabolic parameters, there was a higher prevalence of metabolic syndrome (MS) in patients with HOMA-IR&gt;2.5, with no statistical difference in relation to BMI between studied groups. Values of liver enzymes and serum ferritin were significantly higher in patients with this marker of IR, who had a higher prevalence of non-alcoholic steatohepatitis (NASH) and advanced liver fibrosis. In the multivariate analysis, the clinical diagnosis of MS, hyperferritinemia and the presence of NASH in the liver biopsy were the factors independently associated with the presence of altered HOMA-IR. Conclusion: HOMA-IR values &gt;2.5 identify patients with NAFLD with distinct clinical and metabolic characteristics and with a greater potential for disease progression, which validates this parameter in the identification of patients with MAFLD.<\/jats:p>","DOI":"10.1590\/s0004-2803.202203000-72","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T19:38:42Z","timestamp":1662752322000},"page":"402-407","source":"Crossref","is-referenced-by-count":2,"title":["IS HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE &gt;2.5 A DISTINGUISHED CRITERIA FOR METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IDENTIFICATION?"],"prefix":"10.1590","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6645-8901","authenticated-orcid":false,"given":"B\u00e1rbara Ferreira de Mello","family":"BARRETO","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0833-1344","authenticated-orcid":false,"given":"Giovana Rita","family":"PUNARO","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9307-9509","authenticated-orcid":false,"given":"Maria Cristina","family":"ELIAS","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4890-9259","authenticated-orcid":false,"given":"Edison Roberto","family":"PARISE","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2022,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam M","year":"2020","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam M","year":"2020","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi ZM","year":"2020","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1665-2681(19)31584-4","article-title":"Nonalcoholic fatty liver disease in Brazil: clinical and histological profile","volume":"10","author":"Cotrim H","year":"2011","journal-title":"Ann Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.2009.205088","article-title":"Disease progression of non-alcoholic fatty liver disease: A prospective study with paired liver biopsies at 3 years","volume":"59","author":"Wong VW-S Li MK-P","year":"2010","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","article-title":"A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver","volume":"59","author":"Pais R","year":"2013","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis","volume":"67","author":"Marengo A","year":"2016","journal-title":"Annu Rev Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"Natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams LA","year":"2005","journal-title":"Gastroenterology"},{"issue":"13","key":"ref10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010214","article-title":"Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)","volume":"97","author":"Golabi P","year":"2018","journal-title":"Medicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cld.2019.07.007","article-title":"Portal Hypertension: Pathogenesis and Diagnosis","volume":"23","author":"Turco L","year":"2019","journal-title":"Clin Liver Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert Panel on Detection. Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"year":"1998","series-title":"Obesity: preventing and managing the global epidemic","key":"ref13"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ajcn\/77.2.379","article-title":"Comparisons of waist circumferences measured at 4 sites","volume":"77","author":"Wang J","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews DR","year":"1985","journal-title":"Diabetologia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner DE","year":"2005","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease","volume":"70","author":"Khan RS","year":"2019","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/S0004-28032010000200009","article-title":"Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals","volume":"47","author":"Salgado AL","year":"2010","journal-title":"Arq Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s10620-007-9981-3","article-title":"Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease","volume":"53","author":"Aller R","year":"2007","journal-title":"Dig Dis Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0895-7061(00)01229-2","article-title":"Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension","volume":"14","author":"Lansang MC","year":"2001","journal-title":"Am J Hypertens"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.diabres.2005.10.017","article-title":"The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study","volume":"72","author":"Geloneze B","year":"2006","journal-title":"Diabetes Res Clin Prac"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace TM","year":"2004","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00535-015-1114-8","article-title":"Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery","volume":"51","author":"Seki Y","year":"2016","journal-title":"J Gastroenterol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00125-017-4340-1","article-title":"Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory stud","volume":"60","author":"Isokuortti E","year":"2017","journal-title":"Diabetologia"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini G","year":"1999","journal-title":"Am J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/jfmpc.jfmpc_352_16","article-title":"A study on the altered glycemic and lipid parameters and prevalence of insulin resistance in nonalcoholic fatty liver disease","volume":"7","author":"Suresh S","year":"2018","journal-title":"J Family Med Prim Care"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3350\/cmh.2013.19.2.140","article-title":"The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults","volume":"19","author":"Ju DY","year":"2013","journal-title":"Clin Mol Hepatol"},{"key":"ref28","first-page":"13","article-title":"Beta cell failure: causes and consequences","volume":"123","author":"Kahn SE","year":"2001","journal-title":"Int J Clin Pract"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/0016-5085(90)90478-J","article-title":"Glucose disposal, b-cell secretion, and hepatic insulin extraction in cirrhosis. a minimal model assessment","volume":"99","author":"Marchesini G","year":"1990","journal-title":"Gastroenterology"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192663","article-title":"Insulin resistance in lean and overweight non- diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI","volume":"13","author":"Gonzalez-Cantero J","year":"2018","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1478-3231.2011.02488.x","article-title":"Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients","volume":"31","author":"Manousou P","year":"2011","journal-title":"Liver Int"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11605-007-0158-3","article-title":"Metabolic characterization of nondiabetic severely obese patients undergoing roux-em-Y gastric bypass: preoperative classification predicts the effects of gastric bypass on insulin-glucose homeostasis","volume":"11","author":"Perugini RA","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.dsx.2015.09.005","article-title":"Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults","volume":"10","author":"Hossain IA","year":"2016","journal-title":"Diabetes Metab Syndr"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2008.02415.x","article-title":"Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population","volume":"25","author":"Lee MY","year":"2008","journal-title":"Diab Med"},{"issue":"3","key":"ref35","article-title":"Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload","author":"Brudevold R","year":"2008","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejim.2011.01.011","article-title":"Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome","volume":"22","author":"Zimmermann A","year":"2011","journal-title":"Eur J Intern Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley KV","year":"2012","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988: role of insulin resistance in human disease","volume":"37","author":"Reaven GM","year":"1988","journal-title":"Diabetes"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel RH","year":"2005","journal-title":"Lancet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted with lipoproteins inpatients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly KI","year":"2005","journal-title":"J Clin Invest"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2015.02.018","article-title":"Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?","volume":"418","author":"Asrih M","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/jhep.2001.28055","article-title":"High glucose and hyperinsulinemia stimulate connective tissue. growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis","volume":"34","author":"Paradis V","year":"2001","journal-title":"Hepatology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cld.2004.04.006","article-title":"Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease","volume":"8","author":"Choudhury J","year":"2004","journal-title":"Clin Liver Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0168-8278(99)80039-7","article-title":"Impaired splanchnic and peripheral glucose uptake in liver cirrhosis","volume":"31","author":"Imano E","year":"1999","journal-title":"J Hepatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4254\/wjh.v3.i5.99","article-title":"Insulin resistance and chronic liver disease","volume":"3","author":"Kawaguchi T","year":"2011","journal-title":"World J Hepatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella ME","year":"2015","journal-title":"JAMA"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/138161210791208875","article-title":"Insulin resistance in nonalcoholic fatty liver disease","volume":"16","author":"Bugianesi E","year":"2010","journal-title":"Curr Pharm Des"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt M","year":"2006","journal-title":"Hepatology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso G","year":"2011","journal-title":"Ann Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1590\/1806-9282.63.03.284","article-title":"Hyperferritinemia in patients with nonalcoholic fatty liver disease","volume":"63","author":"Barros RK","year":"2017","journal-title":"Rev Assoc Med Bras"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["O modelo de avalia\u00e7\u00e3o da homeostase para resist\u00eancia \u00e0 insulina &gt;2,5 \u00e9 um crit\u00e9rio distinto para a identifica\u00e7\u00e3o da doen\u00e7a hep\u00e1tica gordurosa associada \u00e0 disfun\u00e7\u00e3o metab\u00f3lica?"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032022000300402&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T16:30:19Z","timestamp":1676737819000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032022000300402&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["S0004-28032022000300402"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.202203000-72","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"type":"electronic","value":"1678-4219"},{"type":"print","value":"0004-2803"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}